Supplement Doses Inadequate for Androgen Deprivation Therapy

Share this article:
Supplement Doses Inadequate for Androgen Deprivation Therapy
Supplement Doses Inadequate for Androgen Deprivation Therapy

(HealthDay News) – Currently recommended calcium and vitamin D supplementation doses are inadequate to prevent bone mineral density (BMD) loss in men undergoing androgen deprivation therapy (ADT) for prostate cancer.

To examine whether currently recommended doses of calcium and vitamin D in men undergoing ADT are adequate to prevent the loss of BMD, Mridul Datta, RD, PhD, and Gary G Schwarz, PhD, MPH, of the Wake Forest Baptist Medical Center in Winston-Salem, NC, conducted a review of 12 clinical trials.

The researchers found that current guidelines recommend calcium supplementation of 500–1,000mg/day and vitamin D doses of 200–500international units/day for men undergoing ADT. According to the results of the clinical trials, however, men continued to lose BMD at these doses.

"The doses of calcium and vitamin D that have been tested are inadequate to prevent loss of bone mineral density in men undergoing androgen deprivation therapy," the authors write. "In light of evidence that high levels of dietary calcium and calcium supplement use are associated with higher risks for cardiovascular disease and advanced prostate cancer, intervention studies should evaluate the safety as well as the efficacy of calcium and vitamin D supplementation in these men."

Abstract
Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs